Santhera Pharmaceuticals Holding AG

SANN CHF0.1
Create an alert
Sell15.54 CHF
Buy15.98 CHF
0.04 CHF (0.25%)
Last updated today at
Trade
Back to dashboard

Company Information

About this company

Santhera Pharmaceuticals Holding AG (Santhera) is a Switzerland-based company engaged in the pharmaceutical sector. The Company operates through one business segment, which is the research, development and commercialization of pharmaceutical products for the treatment of neuromuscular and mitochondrial diseases, such as Duchenne muscular dystrophy (DMD) and cystic fibrosis (CF). The Company focuses also on development of gene therapy for the treatment of LAMA2 (Laminin Subunit Alpha 2) deficient congenital muscular dystrophy (CMD). Santhera operates through its wholly owned subsidiaries: Santhera Pharmaceuticals (Schweiz) AG, Liestal, Santhera Pharmaceuticals (USA) Inc, Santhera Pharmaceuticals (Canada) Inc, Santhera Pharmaceutical (Deutschland) GmbH and Oy Santhera Pharmaceuticals (Finland) Ltd.

Key people

Thomas Meier
Non-Executive Independent Chairman of the Board
Melanie Rolli
Director
Philipp Gutzwiller
Non-Executive Independent Director
Bradley C. Meyer
Non-Executive Independent Director
Dario Eklund
Chief Executive Officer, Member of the Executive Management Board
Orlando Oliveira
Chief Executive Officer
Catherine Isted
Chief Financial Officer, Member of the Executive Management Board
Marc Schrader
Chief Technology Officer
Marc Clausse
Chief Commercial Officer
Oliver P. Kronenberg
Chief Legal Officer, Corporate Secretary, Member of the Executive Management Board
Shabir Hasham
Chief Medical Officer and Member of the Executive Management Board
Srishti Gupta
Director
Click to see more

Key facts

  • Shares in issue
    15.87m
  • EPIC
    SANN
  • ISIN
    CH1276028821
  • Location
    Switzerland
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    CHF 249.18m
  • Employees
    94
  • Exchange
    SIX Swiss Exchange
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.